Revenue up 2.3% to ₹1,160 Cr, maintains exceptional ROCE of 104%
Mumbai, India, November 6, 2025: Procter & Gamble Hygiene and Health Care Limited announced its unaudited financial results for the quarter ended 30th September 2025, delivering steady revenue growth and maintaining exceptional profitability metrics including ROCE of 104% and debt-free balance sheet.
| Financial Metric | Q2 FY26 | Q2 FY25 | YoY Change | Performance |
|---|---|---|---|---|
| Revenue (₹ Cr) | 1,160.97 | 1,135.16 | +2.3% | Steady |
| Profit Before Tax (₹ Cr) | 281.78 | 285.37 | -1.3% | Stable |
| PAT (₹ Cr) | 209.84 | 211.90 | -1.0% | Strong |
| Basic EPS (₹) | 64.65 | 65.28 | -1.0% | Healthy |
Note: The significant improvement in H1 PAT and EPS is primarily due to the change in financial year from June 30th to March 31st, making YoY comparisons more meaningful on quarterly basis.
Procter & Gamble Hygiene and Health Care Limited is one of India's leading players in the fast-moving consumer goods (FMCG) sector, with a strong portfolio of health and hygiene products including feminine care, healthcare, and skin care products.
Overall Performance Assessment: Procter & Gamble Hygiene delivered a steady Q2 FY26 performance with 2.3% revenue growth and maintained strong profitability with PAT of ₹209.84 Cr. The company continues to demonstrate exceptional financial metrics with ROCE of 104% and ROE of 75.7%, supported by a debt-free balance sheet. The stock trades at a premium P/E of 51.6, reflecting the market's confidence in the company's strong brand positioning, consistent performance, and superior return ratios in the FMCG sector.
This article is for educational purposes only and does not constitute investment advice. The financial data and analysis mentioned are based on company filings and market observations. Always verify current information from official sources before investing. Stock market investments carry risks including liquidity risk, volatility, and capital loss risk. Always do your own research and consider consulting with a qualified financial advisor before making investment decisions. Past performance is not indicative of future results.